Characterization of the Open-Label Lead-In Period of Two Randomized Controlled Phase 3 Trials Evaluating Dapagliflozin, Saxagliptin, and Metformin in Type 2 Diabetes
Titel:
Characterization of the Open-Label Lead-In Period of Two Randomized Controlled Phase 3 Trials Evaluating Dapagliflozin, Saxagliptin, and Metformin in Type 2 Diabetes
Auteur:
Mathieu, Chantal Catrinoiu, Doina Ranetti, Aurelian Emil Johnsson, Eva Hansen, Lars Chen, Hungta Garcia-Sanchez, Ricardo Iqbal, Nayyar CeliƱski, Aleksander